Pharma Japan
Subscription Required: Yes
Pharma Japan provides up-to-date news, insights, and analysis on the Japanese pharmaceutical industry, including regulatory changes, market trends, and company developments. LATEST NEWS
- MHLW Allows Exceptional Concerta Pharmacy Transfers
- Merck Biopharma Starts Japan PIII Trial of LH/FSH Combo
- Eisai’s Dayvigo Accepted for EMA Review
- AbbVie Files Maviret for Acute Hepatitis C
- AMED-Backed R&D Yielded 31 Regulatory Approvals in FY2025
- MHLW to Reconvene HSC Regulation Panel for First Time in a Year
- Ferring’s Adstiladrin, Boehringer’s Jascayd Hit Market; Haizexin Due July 28